Penumbra Inc

Penumbra Inc. shows high‑valuation growth and market volatility, with a focus on neurovascular devices; investors await fresh data to gauge future stability.

Penumbra Inc. (PEN) balances a promising neuro‑vascular expansion pitch at Piper Sandler with a surprising insider sell‑off, prompting investors to weigh growth prospects against potential risks.